Switch View
© Globe Newswire
09.10.2025
ISIN: DK0060448595
Coloplast A/S
COLO B
LISTED
CPH
Coloplast interim CEO Lars Rasmussen will step down from the Board at the upcoming Annual General Meeting
News Preview
Announcement no. 09/2025Inside information ...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: CH0363463438
Idorsia Ltd
IDIA
LISTED
SIX
Idorsia launches an offering of registered shares – to fund the company to overall profitability
News Preview
Ad hoc announcement pursuant to Art. 53 LR...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US28106W1036
Editas Medicine Inc
EDIT
LISTED
NASDAQ
Editas Medicine Reports In Vivo Proof-of-Concept Data for EDIT-401 at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress
News Preview
Preclinical data demonstrates proof-of-concept for EDIT-401 with ≥90% mean LDL-C reduction in non-human primates and mouse models Preclinical data demonstrates proof-of-concept for EDIT-401 with ≥90% mean LDL-C reduction in non-human primates and mouse models...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
09.10.2025
ISIN: US5747951003
Masimo Corporation
MASI
LISTED
NASDAQ
Masimo to Host Investor Day on December 3, 2025
News Preview
Masimo (NASDAQ: MASI) today announced it will host a meeting with the analyst and investor community at 9:00am PT on Wednesday, December 3, 2025.
Presentations will be led by select members of the Executive Leadership Team and will cover an overview of the company’s business, market opportunities, innovation pipeline, commercial growth strategy,...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
09.10.2025
ISIN: US4330001060
Hims & Hers Health Inc
HIMS
LISTED
NYSE
Customers Say Care Through Hims & Hers Matches, or Beats, the Doctor’s Office
News Preview
Hims & Hers Health, Inc. (NYSE: HIMS) today published a new white paper - Understanding Hims & Hers Approach to Clinical Excellence, Quality, and Safety - detailing how rigorous standards, continuous monitoring, and customer-centered design are shaping the future of safe and effective telehealth.
“At Hims & Hers, we believe that digi...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: CNE100003N76
Shanghai Henlius Biotech, Inc.
2696
LISTED
HKSE
Phase 3 Clinical Trial of HANSIZHUANG Plus Chemotherapy Meets Primary Endpoint in Neoadjuvant/Adjuvant Gastric Cancer, Greenlighting Early NDA Submission
News Preview
The phase 3 clinical trial of HANSIZHUANG for perioperative gastric cancer treatment met its EFS primary endpoint, supporting an early New Drug Application (NDA) submission
World-first regimen in gastric cancer that replaces adjuvant chemotherapy with mono-immunotherapy in the perioperative sett...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Investors who lost money on Lantheus Holdings, Inc.(LNTH) should contact The Gross Law Firm about pending Class Action - LNTH
News Preview
NEW YORK, Oct. 9, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Lantheus Holdings, Inc. (NASDAQ: LNTH).
Shareholders who...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
The Gross Law Firm Notifies Shareholders of Semler Scientific, Inc.(SMLR) of a Class Action Lawsuit and an Upcoming Deadline
News Preview
NEW YORK, Oct. 9, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Semler Scientific, Inc. (NASDAQ: SMLR).
Shareholders who...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 25, 2025 in LifeMD, Inc. Lawsuit - LFMD
News Preview
NEW YORK, Oct. 9, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of LifeMD, Inc. (NASDAQ: LFMD).
Shareholders who purchased...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Nutex Health Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - NUTX
News Preview
NEW YORK, Oct. 9, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX).
Shareholders who purch...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Shareholders that lost money on Savara Inc.(SVRA) should contact The Gross Law Firm about pending Class Action - SVRA
News Preview
NEW YORK, Oct. 9, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Savara Inc. (NASDAQ: SVRA).
Shareholders who purchased s...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Cytokinetics, Incorporated Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before November 17, 2025 to Discuss Your Rights - CYTK
News Preview
NEW YORK, Oct. 9, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cytokinetics, Incorporated (NASDAQ: CYTK).
Shareholders...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
09.10.2025
ISIN: US30050B1017
Evolent Health Inc
EVH
LISTED
NYSE
Evolent To Release Third Quarter 2025 Financial Results on Thursday, November 6, 2025
News Preview
Company to Participate in Upcoming Conferences
WASHINGTON, Oct. 9, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its third quarter...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US88023B1035
Tempus AI, Inc.
TEM
LISTED
NASDAQ
Tempus Selected by ARPA-H to Provide CRO and Testing Services for the ADAPT Program, Advancing Precision Cancer Therapy
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced it has been selected by the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services, to provide testing and contract research organization (CRO) services in s...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: CNE100003N76
Shanghai Henlius Biotech, Inc.
2696
LISTED
HKSE
Phase 3 Clinical Trial of HANSIZHUANG Plus Chemotherapy Meets Primary Endpoint in Neoadjuvant/Adjuvant Gastric Cancer, Greenlighting Early NDA Submission
News Preview
The phase 3 clinical trial of HANSIZHUANG for perioperative gastric cancer treatment met its EFS primary endpoint, supporting an early New Drug Application (NDA) submission
World-first regimen in gastric cancer that replaces adjuvant chemotherapy with mono-immunotherapy in the perioperative sett...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US3179701012
Firefly Neuroscience, Inc.
AIFF
LISTED
NASDAQ
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Firefly Neuroscience, Inc. (NASDAQ: AIFF)
News Preview
NEW YORK, Oct. 9, 2025 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Firefly Neuroscience, Inc. (NASDAQ: AIFF) on behalf of the company's shareholders. The investigation seeks to determine whether Firefly Neuroscience's directors breached their fiduciary duties in connection with...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: IE00BGH1M568
Perrigo Company PLC
PRGO
LISTED
NYSE
Opill® Nails It with First-Ever Brand Collaboration, Launching 'Opill and Chill' With Chillhouse
News Preview
Brands Will Donate One Pack of Opill® to NY Birth Control Access Project for Each Opill®-Themed Chill Tips Set Sold
GRAND RAPIDS, Mich., Oct. 9, 2025 /PRNewswire/ -- Today, Perrigo Company plc (NYSE: PRGO), a leading provi...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US00287Y1091
AbbVie Inc
ABBV
LISTED
EURONEXT
SkinMedica® Debuts Reimagined Packaging and Unveils New HA5® Hydra Collagen Water Burst Moisturizer
News Preview
By the makers of BOTOX® Cosmetic (onabotulinumtoxinA), SkinMedica®'s new packaging features a refreshed logo, modernized look, and luxe copper color palette.
The brand's new HA5® moisturizer
is designed to support...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: VGG312491084
Establishment Labs Holdings Inc
ESTA
LISTED
NASDAQ
Establishment Labs Publishes 15 Years of Motiva Data in 2025 Post-Market Surveillance Report
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced publication of its 2025 Post-Market Surveillance (PMS) Report. The report is being released ahead of the annual meeting of the American Society of Pl...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US04635X1028
Astria Therapeutics Inc
ATXS
LISTED
NASDAQ
Astria Therapeutics to Present at Upcoming CSACI 80th Anniversary Scientific Meeting
News Preview
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will present two posters at the Canadian Society of Allergy and Clinical Immunology (CSACI) 80th Anniversary Scientific Meeting, taking place October 15-18, 2025 in Vancou...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US00973Y1082
Akero Therapeutics Inc
AKRO
LISTED
NASDAQ
AKRO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Akero Therapeutics, Inc. Is Fair to Shareholders
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Akero Therapeutics, Inc. (NASDAQ: AKRO) to Novo Nordisk A/S is fair to Akero shareholders. Under the terms of the proposed transaction, Akero shareholders will receive $54.00 per share in cash, and a non-transferable Contingent Value Right entitling its holder to r...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US81663L2007
GeneDx Holdings Corp
WGS
LISTED
NASDAQ
GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program
News Preview
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the Autism Partnership Program to expand access to its industry leading exome and genome testing – the only autism testing program committed to delivering answers to families in weeks. Jaguar Gene Therapy joins the program as the foundin...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US36266G1076
GE Healthcare Technologies Inc
GEHC
LISTED
NASDAQ
GE HealthCare unveils Carestation 850 at ANESTHESIOLOGY 2025: its next-generation anesthesia delivery system designed to adapt to care needs
News Preview
GE HealthCare (Nasdaq: GEHC) today announced the unveiling of Carestation™ 850, its next-generation, FDA 510(k) pendingi anesthesia delivery system that is designed to help care teams adapt to evolving clinical and operational needs. Marking the latest evolution of GE HealthCare’s Carestation portfolio, Carestation 850 has the potential to advance...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: FR0014000MR3
Eurofins Scientific SE
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS...
Themefolio
Profiler
Peergroup
© Newsfile
09.10.2025
ISIN: US68764Y2072
OS Therapies, Inc
OSTX
LISTED
XASE
OS Therapies Provides Positive EMA Regulatory Update Following Positive Rapporteur Meeting
News Preview
Overall survival recognized as key efficacy endpoint in osteosarcoma, where no standard of care existsRapporteur highlights potential broader benefits of OST-HER2 in pulmonary and primary osteosarcoma settings, supported by translational canine data from the University of PennsylvaniaNew York, New York--(Newsfile Corp. - October 9, 2025) - OS Thera...
Themefolio
Profiler
Peergroup
© Newsfile
09.10.2025
ISIN: CA74447P1009
Psyched Wellness Ltd
PSYC
LISTED
CSE
Psyched Wellness Provides Comprehensive Investor Update
News Preview
Toronto, Ontario--(Newsfile Corp. - October 9, 2025) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company specializing in the production and distribution of health and wellness products derived from the Amanita Muscaria mushroom, is pleased to provide the following corporate update to i...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US75901B1070
Regenxbio Inc
RGNX
LISTED
NASDAQ
REGENXBIO Announces Presentation at the American Academy of Ophthalmology 2025 Annual Meeting
News Preview
ROCKVILLE, Md., Oct. 9, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will present interim data from the Phase II ALTITUDE® trial evaluating suprachoroidal delivery of surabgene lomparvovec (ABBV-RGX-314, sura-vec) for the treatment of diabetic retinopathy (DR) at the American Academy...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Biopharma Leaders Advance the Future of Life Sciences at Veeva Commercial Summit Europe
News Preview
Industry gathers to explore Veeva AI innovations and exchange ideas with companies including Astellas, Bayer AG, Boehringer Ingelheim, LEO Pharma, Moderna, and MSD
BARCELONA, Spain, Oct. 9, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Ast...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: IL0011595993
InMode Ltd.
INMD
LISTED
NASDAQ
InMode to Report Third Quarter 2025 Financial Results and Hold Conference Call on November 5, Expects Q3 Revenue Between $92.5M-$93.0M, Reiterates FY 2025 Guidance Between $365M-$375M
News Preview
Conference call to be held on Wednesday, November 5, 2025, at 8:30 a.m. Eastern Time
YOKNEAM, Israel, Oct. 9, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the thir...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: GB00BP6S8Z30
Oxford Nanopore Technologies PLC
ONT
LISTED
LSE
Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032
News Preview
Grants Bio-Techne expanded commercial rights to develop a portfolio of genetics products beyond the recently launched AmplideX® Nanopore Carrier Plus Kit
Establishes a framework to define and propose future portfolios
Extends collaboration through 2032, reinforcing Bio-Techne's...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US64051A1016
NeOnc Technologies Holdings Inc
NTHI
LISTED
NASDAQ
NeOnc Technologies' Subsidiary, NuroMENA, Signs Master Services Agreement with M42’s IROS and Expands Board of Directors
News Preview
CALABASAS, Calif. and ABU DHABI, United Arab Emirates, Oct. 09, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering therapies for central nervous system (CNS) cancers, has announced two major strategic developments that solidify its expan...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US64135M1053
Neurogene Inc
NGNE
LISTED
NASDAQ
Neurogene Announces Positive Regulatory Update for NGN-401 Gene Therapy in Rett Syndrome with Plans to Initiate Dosing in Embolden™ Registrational Trial in Q4 2025
News Preview
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced the Company has completed discussions with the U.S. Food and Drug Administration (FDA) on its Embolden™ registrational trial protocol and plans to initiate dosing...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US6404911066
Neogen Corp
NEOG
LISTED
NASDAQ
Neogen Announces First-Quarter 2026 Results
News Preview
Neogen Corporation (NASDAQ: NEOG) announced today the results of the first quarter ended August 31, 2025.
“I see tremendous opportunity ahead to leverage Neogen’s strong, longstanding leadership in food and animal safety,” said Mike Nassif, Neogen’s Chief Executive Officer and President. “Few companies are as well-positioned as we are to help sh...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
Merck to Present New Data from HIV Treatment and Prevention Pipeline at European AIDS Conference 2025
News Preview
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that it will present new findings from its HIV treatment and prevention pipeline at the 20th European AIDS Conference (EACS 2025) taking place Oct.15-18, 2025, in Paris, France. The company’s presentations will include:
An oral presentation of weight and bo...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US0758871091
Becton Dickinson and Co
BDX
LISTED
NYSE
BD Reaches Major Milestone for Rotarex™ Catheter System with First Patient Enrolled in XTRACT™ Registry to Advance Real-World Evidence in Peripheral Artery Disease
News Preview
FRANKLIN LAKES, N.J., Oct. 9, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the enrollment of the first patient in the XTRACT™ Registry, a prospective, multi-center, single-arm, post-market registry study designed to evaluate the...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
Merck Advances Oncology Innovation, Highlighting Progress in New Tumor Types and Earlier Stages of Disease at ESMO 2025
News Preview
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new research from more than 100 abstracts across more than 20 types of cancer and multiple treatment settings from the company’s broad and differentiated portfolio and pipeline will be presented at the European Society for Medical Oncology (ESMO) Congress 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: DK0015998017
Bavarian Nordic A/S
BAVA
LISTED
CPH
Consortium consisting of Nordic Capital and Permira receives final regulatory approval in respect of its takeover offer to the shareholders of Bavarian Nordic
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US14888U1016
Catalyst Pharmaceuticals Inc
CPRX
LISTED
NASDAQ
Catalyst Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences
News Preview
CORAL GABLES, Fla., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing and commercializing novel medicines for people living with rare and difficult-to-treat diseases, today announced that data developed by or in conjunction...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: GB0009895292
AstraZeneca PLC
AZN
LISTED
LSE
Turbine Launches Collaboration with AstraZeneca, Leveraging Turbine's Virtual Disease Models to Rationalize ADC Discovery
News Preview
LONDON, UK and BUDAPEST, HUNGARY, Oct. 9, 2025 /PRNewswire/ -- Turbine, a leading company specializing in virtualizing biological experiments with AI, today announced a collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN) to test the ability of Turbine's platform to rationalize antibody-drug conjugate (ADC) disco...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US9553061055
West Pharmaceutical Services Inc
WST
LISTED
NYSE
West to Host Third-Quarter 2025 Conference Call
News Preview
EXTON, Pa., Oct. 9, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter financial results before the market opens on Thursday, October 23, 2025, and will follow with a co...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US68572M1062
Orchestra Biomed Holdings Inc
OBIO
LISTED
NASDAQ
Orchestra BioMed to Showcase Transformative Potential of AVIM Therapy in Keynote Presentation on Hypertensive Heart Disease at Georgia Innovation Summit
News Preview
NEW HOPE, Pa., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with market-leading global medical device companies, today announced a data summary supporting the transformativ...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US1717571079
Cidara Therapeutics, Inc.
CDTX
LISTED
NASDAQ
Cidara Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for CD388 in Seasonal Influenza Prevention
News Preview
Breakthrough Therapy designation comes in addition to previously awarded Fast Track designation Breakthrough Therapy designation comes in addition to previously awarded Fast Track designation...
Themefolio
Profiler
Peergroup
© Newsfile
09.10.2025
ISIN: CA41138T1057
Happy Belly Food Group Inc.
HBFG
LISTED
CSE
Happy Belly Food Group Announces New Franchise Agreement and Real Estate Signed for Heal Wellness in Cochrane, Alberta
News Preview
Toronto, Ontario--(Newsfile Corp. - October 9, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands across Canada is pleased to announce the signing of a franchise agreement and secured real estate for Cochrane, Alberta -a key market within the Compan...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: CA68617J1003
Organigram Global Inc
OGI
LISTED
NASDAQ
Organigram Global Launches happly, a New U.S. Hemp-Derived THC Brand Offering Targeted Formulations for Three Mood States; Socialize, Relax, and Sleep
News Preview
Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada’s #1 cannabis company by market share, is pleased to announce the launch of happly, its third U.S. hemp-derived delta-9 brand, created specifically for the growing segment of consumers seeking ‘mindful recreation’ with THC products. The launch of happly follow...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US7473241013
Pyxis Oncology Inc
PYXS
LISTED
NASDAQ
Pyxis Oncology Appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets
News Preview
BOSTON, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing antibody-drug conjugate (ADC) therapeutics for difficult-to-treat cancers, today announced the appointment of Alex Kane, MBA, as Senior Vice President, Investor Relations & Capital Markets, effective immediately....
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US00887A2042
Rein Therapeutics Inc
ALRN
LISTED
NASDAQ
Rein Therapeutics Receives European Regulatory Approval to Initiate Phase 2 Trial of LTI-03 in Idiopathic Pulmonary Fibrosis
News Preview
AUSTIN, Texas, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications, today announced that it has received authorization from the European Medicines Agenc...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US88688T1007
Tilray Brands Inc
TLRY
LISTED
TSX
Tilray Brands Reports Strong First Quarter Fiscal 2026 Results, Highlighting Continued Growth with Record Q1 Net Revenue of $210 Million and Net Income
News Preview
Operational Efficiencies and Focus on Profitability Drove Net Income of $1.5 Million, Adjusted EBITDA Increased 9% to $10 Million and Net Cash Used in Operations Improved by $34 Million Year-Over-Year...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US36269B1052
Gain Therapeutics, Inc.
GANX
LISTED
NASDAQ
Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson’s Disease
News Preview
Event to be held October 14th at 4 p.m. EST Event to be held October 14th at 4 p.m. EST...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US53220K5048
Ligand Pharmaceuticals Inc
LGND
LISTED
NASDAQ
Ligand Partner SQ Innovation Receives FDA Approval for Lasix® ONYU, an At-Home Treatment for Edema in Heart Failure Patients
News Preview
Ligand Partner SQ Innovation Receives FDA Approval for
Lasix® ONYU, an At-Home Treatment for Edema in Heart Failure Patients...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: SE0011205202
Vitrolife AB
VITR
LISTED
STO
Invitation to Vitrolife Group's presentation of the Q3 2025 interim report
News Preview
GOTHENBURG, Sweden, Oct. 9, 2025 /PRNewswire/ -- Vitrolife AB (publ) will publish its Q3 2025 interim report on Thursday, 23 October 2025 at 08:00 am CEST. A conference call for investors, analysts and financial media will be held at 10:00 am CEST the same day.
The presentation will be held in Eng...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US00973Y1082
Akero Therapeutics Inc
AKRO
LISTED
NASDAQ
Akero Therapeutics to be Acquired by Novo Nordisk for up to $5.2 Billion
News Preview
Shareholders to Receive $54 Per Share in Cash and CVR of $6 Per Share ...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US98985Y1082
Zymeworks Inc
ZYME
LISTED
NYSE
Zymeworks Appoints Dr. Adam Schayowitz as Acting Chief Development Officer
News Preview
VANCOUVER, British Columbia, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease, today announced the ap...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US3968791083
Greenwich Lifesciences Inc
AZRGF
LISTED
OTC
Greenwich LifeSciences Announces Addition of Austria to Flamingo-01 Clinical Trial
News Preview
STAFFORD, Texas, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced the expansion of FLAMINGO-01 clinical...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: DK0062498333
Novo Nordisk A/S
NOVO B
LISTED
CPH
Novo Nordisk to acquire Akero Therapeutics and its promising phase 3 FGF21 analogue to expand MASH portfolio
News Preview
Bagsværd, Denmark, 9 October, 2025 – Novo Nordisk today announced that it has entered into a definitive agreement to acquire Akero Therapeutics, Inc. (Akero), a publicly held clinical-stage company developing innovative treatments for patients with serious metabolic diseases marked by a high unmet medical need. Akero’s fibroblast growth factor 21 (...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
09.10.2025
ISIN: US87975F1049
Telomir Pharmaceuticals, Inc.
TELO
LISTED
NASDAQ
Telomir Pharmaceuticals Reports Discovery That Telomir-1 Selectively Kills Aggressive Triple-Negative Breast Cancer Cells
News Preview
New findings show Telomir-1 shuts down cellular energy pathways and mitochondrial function in aggressive breast cancer cells, leading to cell death through iron-dependent regulation. MIAMI, FL, 2654 / ACCESS Newswire / October 9, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a preclinical-stage...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: KYG3224E1061
Everest Medicines Limited
1952
LISTED
HKSE
Everest Medicines Announces Publication of Etrasimod's Asian Multicenter Phase III ENLIGHT UC study (ES101002) Results in The Lancet Gastroenterology & Hepatology
News Preview
The published study results are from the ENLIGHT UC study (ES101002), a multicenter, randomized, double-blind and placebo-controlled Phase III trial of etrasimod conducted across Asia. The study included a 12-week induction phase followed by a 40-week maintenance phase and represents the largest pivotal Phase III...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
09.10.2025
ISIN: CA0717341071
Bausch Health Companies Inc
BHC
LISTED
TSX
Bausch Health Announces Results of Special Meeting of Shareholders
News Preview
LAVAL, QC / ACCESS Newswire / October 9, 2025 / Bausch Health Companies Inc. (the "Company") (NYSE:BHC)(TSX:BHC) today announced the results of the special meeting of shareholders held on October 7, 2025 (the "Shareholders Meeting"). At the Shareholders Meeting, shareholders of the Company approved the ratification, confirmation...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
09.10.2025
ISIN: CA53946V2066
Lobe Sciences Ltd.
LOBE
LISTED
CSE
Lobe Sciences Improves Balance Sheet
News Preview
VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / October 9, 2025 / Lobe Sciences Ltd. ("Lobe" or the "Company") (CSE:LOBE)(OTCQB:LOBEF)(FWB:LOBE.F), operates as a pharmaceutical platform that develops novel therapies through a scalable model of shared services, global teams, and outsourced infrastructure. The Company creates inte...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
NUTX Deadline: NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 8, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NU...
Themefolio
Profiler
Peergroup
© Newsfile
09.10.2025
ISIN: CA00654D1006
Adastra Holdings Ltd.
XTRX
LISTED
CSE
Adastra Holdings Enters into Agreements to Sell Subsidiaries
News Preview
Langley, British Columbia--(Newsfile Corp. - October 8, 2025) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2E0) (the "Company") announces that it has entered into agreements to sell all of the issued and outstanding shares of its wholly-owned subsidiaries, Adastra Labs Holdings (2019) Ltd. ("Adastra Labs"), 1178562 B.C. Ltd. ("1178562"), an...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
